Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 86.28

-0.4%

Feb 9 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Jibacoa	2/29/2016 11:27:07 AM
	of 3722

KERX is up 19.51% on volume of 2,524,072 already above its ADV.<g> It reported its 4thQ results last Thursday, with losses larger than expected. It had some bearish comments after that from Zacks and JPMorgan But it started recovering on Friday and today after an upgrade by FBR Capital and some bullish comments from Barron's albeit it cut its "target" from 11 to 5.<g> Auryxia U.S. revenues continue to increase slowly and KERX said it finished the Q with $200Ms in Csh, enough according to them to continue developing Auryxia to breakeven.<g> Will see if the stock could get back to the $5 level or if it could retest its double top at $6 before closing today's UG.<g> elite.finviz.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next